Medtronic develops new stent for peripheral artery disease
Medtronic Inc has developed a new device for the treatment of peripheral artery disease. This new FDA approved device, dubbed the Assurant Cobalt Iilac Balloon Expandable Stent System has already...
View ArticleAnalysis: Comparing the latest stents from rivals Abbott and Medtronic
On October 31st, the company Medtronic received US Federal Food and Drug Administration approval to treat Narrow Iliac arteries with the use of the Cobalt Chromium Balloon Expendable Stent. A day...
View ArticleFDA approves the stent of Boston Scientific
Boston Scientific announced its next-generation drug-eluting stent was approved by the Federal Food and Drug Administration. With it’s innovative platinum chromium design, the PROMUS Element Plus...
View ArticleClinical trials begin for bioresorbable peripheral artery disease treatment
Today, Abbott announced the start of European clinicals trial to evaluate its new Esprit™ drug eluting bioresorbable vascular scaffold (BVS) for the treatment of blockages in the peripheral arteries....
View ArticleNovel treatment for artery disease has advantages over conventional treatments
A new treatment for coronary and peripheral artery disease is superior to corresponding conventional treatments. Two IN.PACT drug-eluting balloons, produced by Medtronic, Inc., were tested in...
View ArticleNew stent comes with low risk of complications for patients with and without...
A new stent produced by Medtronic, Inc. has shown to perform strongly in coronary artery disease (CAD) patients with and without diabetes. The Resolute Integrity drug-eluting stent (DES) was approved...
View ArticleImproved system for treating abdominal aortic aneurysm
An alternative to major surgery for the repair of abdominal aortic aneurysms (AAA) will soon be available in the US. Medtronic, Inc. announced the US launch of its Endurant II Stent Graft System...
View ArticleStent graft system for early clinical evaluation
Medtronic, Inc. is developing a new stent graft system designed to repair thoracic aortic aneurysm. It has been selected by the FDA for an early feasibility pilot program, allowing it to be evaluated...
View Article